Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Immunotherapy in Melanoma Patients With Brain Metastases Treated With Steroids

NCT03563729 is registered in ClinicalTrials.gov with Inge Marie Svane as lead sponsor.

NCT NCT03563729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03563729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Immunotherapy in Melanoma Patients With Brain Metastases Treated With Steroids
Lead sponsor
Inge Marie Svane
Phase
Phase 2
Overall status
Recruiting
Start date
June 6, 2018
Completion date
June 6, 2028
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma